Data from FDA-advised study demonstrates Lumee™ Oxygen tissue monitoring is a safe and effective long-term method in PAD patients and will support potential FDA submission; strongly correlates with tr ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback